Organon And Co 's (OGN) Outlook - CSIMarket
CSIMarket
 
Organon and Co   (NYSE: OGN)
 



  Organon and Co Outlook

On October 9 2024 the Organon and Co provided following guidance

nnOrganon and Co. to Announce Third Quarter 2024 Earnings and Host Investor Call on October 31, 2024nn

nnJERSEY CITY, N.J.nn – Organon (NYSE: OGN), a global leader in healthcare dedicated to women's health, is set to release its financial results for the third quarter of 2024 on October 31, 2024. The company will hold a webcast and conference call that morning at 8:30 a.m. EDT to discuss the results in detail.

In its financial guidance, Organon anticipates incurring a milestone expense of $51 million during the third quarter, which is expected to have a notable effect on the company's earnings. Specifically, this expense is projected to reduce both Generally Accepted Accounting Principles (GAAP) and non-GAAP earnings per share by approximately $0.16.

As part of its ongoing commitment to transparency and investor engagement, Organon will provide further insights into its performance and strategic initiatives during the call, allowing stakeholders to gain a comprehensive understanding of the company's financial health.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.